An evaluation of the FDA Responder Endpoint for IBS‐C clinical trials: analysis of data from linaclotide Phase 3 clinical trialsJ MacDougall, Anthony J Lembo, Valerie Williams et al.|Neurogastroenterology & Motility|2013Cited by 30
Psychometric validation of symptom severity measures in irritable bowel syndrome with constipationValerie Williams, J. Martin Johnston, Lauren Nelson et al.|Alimentary Pharmacology & Therapeutics|2014Cited by 8